ArticleTheranostics2020

Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation.

Peng Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.